製品の概要

  • 製品名Anti-Dysadherin antibody
    Dysadherin 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to Dysadherin
  • アプリケーション適用あり: WBmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Synthetic peptide conjugated to KLH, corresponding to a region within internal sequence amino acids 70-100 of Human Dysadherin (NP_001158077.1, NP_659003.1).

  • ポジティブ・コントロール
    • CEM cell lysate

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab123676 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/100 - 1/500. Predicted molecular weight: 19 kDa.

ターゲット情報

  • 機能Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis.
  • 配列類似性Belongs to the FXYD family.
  • 翻訳後修飾Glycosylated.
  • 細胞内局在Membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • Dysad antibody
    • Dysadherin antibody
    • FXYD 5 antibody
    • FXYD domain containing ion transport regulator 5 antibody
    • FXYD domain-containing ion transport regulator 5 antibody
    • Fxyd5 antibody
    • FXYD5_HUMAN antibody
    • FXYD5RIC antibody
    • HSPC 113 antibody
    • HSPC113 antibody
    • IWU 1 antibody
    • IWU1 antibody
    • KCT 1 antibody
    • KCT1 antibody
    • Keratinocytes associated transmembrane protein 1 antibody
    • OIT 2 antibody
    • OIT2 antibody
    • PRO 6241 antibody
    • PRO6241 antibody
    • RIC antibody
    see all

Anti-Dysadherin antibody 画像

  • Anti-Dysadherin antibody (ab123676) at 1/100 dilution + CEM cell lysate at 35 µg

    Predicted band size : 19 kDa

Anti-Dysadherin antibody (ab123676) 使用論文

ab123676 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab123676.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"